Small molecule products represent 72.6% of the molecule type category and retail pharmacies account for 59.1% of sales channel demand in 2026. The generic oncology drugs market is estimated at USD 24.4 billion in 2026 and is forecast to post a 2.6% CAGR between 2026 and 2036.